Evidence map›Paper›PMID 38402530›Full record

Trial reportQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2024

Mapping of Family Reported Outcome Measure (FROM-16) scores to EQ-5D: algorithm to calculate utility values.

R Shah, M S Salek, A Y Finlay, R Kay, S J Nixon, K Otwombe, F M Ali, J R Ingram

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
9.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Validation of the FROM-16 in family members of patients receiving advanced therapy medicinal product (ATMP).Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

R ShahDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK. ShahR45@cardiff.ac.uk.ORCID http://orcid.org/0000-0001-8158-712X
M S SalekSchool of Life & Medical Sciences, University of Hertfordshire, Hatfield, UK.ORCID http://orcid.org/0000-0002-4612-5699
A Y FinlayDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.ORCID http://orcid.org/0000-0003-2143-1646
R KayRK Statistics, Bakewell, UK.ORCID http://orcid.org/0000-0001-8968-0951
S J NixonMultiple Sclerosis Society, Cardiff, UK.
K OtwombeStatistics and Data Management Centre, Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.ORCID http://orcid.org/0000-0002-7433-4383
F M AliDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.ORCID http://orcid.org/0000-0002-4184-2023
J R IngramDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.ORCID http://orcid.org/0000-0002-5257-1142
Cardiff University · GBMultiple Sclerosis Society · GBUniversity of Hertfordshire · GBUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAlthough decision scientists and health economists encourage inclusion of family member/informal carer utility in health economic evaluation, there is a lack of suitable utility measures comparable to patient utility measures such those based on the EQ-5D. This study aims to predict EQ-5D-3L utility values from Family Reported Outcome Measure (FROM-16) scores, to allow the use of FROM-16 data in health economic evaluation when EQ-5D data is not available.

methodsData from 4228 family members/partners of patients recruited to an online cross-sectional study through 58 UK-based patient support groups, three research support platforms and Welsh social services departments were randomly divided five times into two groups, to derive and test a mapping model. Split-half cross-validation was employed, resulting in a total of ten multinomial logistic regression models. The Monte Carlo simulation procedure was used to generate predicted EQ-5D-3L responses, and utility scores were calculated and compared against observed values. Mean error and mean absolute error were calculated for all ten validation models. The final model algorithm was derived using the entire sample.

resultsThe model was highly predictive, and its repeated fitting using multinomial logistic regression demonstrated a stable model. The mean differences between predicted and observed health utility estimates ranged from 0.005 to 0.029 across the ten modelling exercises, with an average overall difference of 0.015 (a 2.2% overestimate, not of clinical importance).

conclusionsThe algorithm developed will enable researchers and decision scientists to calculate EQ-5D health utility estimates from FROM-16 scores, thus allowing the inclusion of the family impact of disease in health economic evaluation of medical interventions when EQ-5D data is not available.

Indexed as

AlgorithmsQuality of LifeCross-Sectional StudiesHumansPatient Reported Outcome MeasuresSurveys and QuestionnairesEQ-5DFamily member/partnerFROM-16Health economic evaluationHealth technologyInformal carerQuality of lifeResponse mappingUtility values

Identifiers

PMID38402530
PMCPMC10973087
OpenAlexW4392143353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.